期刊文献+

CD137和CD28分子对衰老T细胞活化的调节作用 被引量:3

Regulation effect of CD137 and CD28 on aged T cell activation
原文传递
导出
摘要 目的观察两种共刺激分子CD137及CD28对D-半乳糖致亚急性衰老模型小鼠及自然衰老小鼠T细胞活化后的细胞增殖、白介素2(IL-2)分泌及细胞存活的影响。方法7周龄BALB/c雄性小鼠随机分为D-半乳糖致亚急性衰老模型组(衰老模型组)、对照组和青年组,衰老模型组小鼠每日背部皮下注射D-半乳糖溶液(120 mg/kg,溶于0.1 ml蒸馏水中),连续注射5个月,建立亚急性衰老小鼠模型;对照组小鼠每日背部皮下注射0.1 ml蒸馏水,连续注射5个月;青年组小鼠未行处理。自然衰老组为16月龄BALB/c雄性小鼠。分离各组小鼠的脾脏T细胞,分别用ConA+ IgG、ConA+CD137单抗、ConA+CD28单抗体外活化,测定T细胞的增殖水平、培养上清液中IL-2的浓度及细胞凋亡率。结果(1)衰老模型组T细胞经ConA+IgG活化后,细胞增殖、IL-2的分泌水平(A值)及细胞存活率分别为0.422±0.057、0.632±0.066及68.0%±2.4%,与自然衰老组T细胞经ConA+IgG活化后的相应指标的差异无统计学意义,但两组衰老T细胞的活化指标均显著低于ConA+IgG活化的青年组及对照组;(2)衰老模型组T细胞应用ConA+CD137单抗活化后,细胞增殖、IL-2的分泌水平分别为0.639±0.053、1.119±0.035,显著高于ConA+IgG活化组,细胞存活率为53.3%±2.4%,显著低于ConA+IgG活化组,自然衰老组也显示同样的结果;并且发现CD137单抗对衰老T细胞功能的调节作用弱于CD28单抗。结论(1)衰老模型组与自然衰老组的T细胞功能均降低,呈现相似的增龄性变化;(2)CD137及CD28分子对两组衰老T细胞有近似的调节作用,均能促进衰老T细胞的活化及存活,CD28分子的调节作用强于CD137分子。 Objective To investigate the effect of co-stimulatory molecular CD137 and CD28 on the cell proliferation, IL 2 secretion and cell apoptotic rate of activated T cells in naturally senile mice and subacute senile mice induced by D-galactose. Methods Seven-week-old BALB/c male mice were divided into D-galactose induced subacute senile group (D-gal group), control group and young group randomly. Subacute senile mice model was established by back hypodermic injection of D-galactose (120 mg/kg, dissolved in 0. 1 ml distilled water) everyday for five month. Control group was established by injection of 0.1 ml distilled water everyday for five month. Young group was injected with nothing. And 16-month-old BALB/c male mice was taken as aged group. The spleen T cells of each group were isolated and activated in vitro stimulation with ConA+ IgG, ConA+ CD137mAb or ConA+ CD28mAb. The cell proliferation, apoptotic rate and IL-2 concentration in cell culture supernate of T cells were detected. Results (1) The cell proliferation(0. 422 ±0. 057, A), IL-2 secretion(0. 632±0. 066, A)and apoptotic rate(68.0% ±2.4%) of T cells in D-gal group stimulated in vitro with ConA+ IgG showed no significant difference when compared with those of aged group. Compared with young and control group, activation of T cell in D-gal and aged groups were significantly decreased; (2) Cell proliferation, IL-2 secretion and cell survival of T cells in D-gal group and aged group were significantly promoted by both ConA + CD137mAb [-( 0. 639 ± 0.053, A), (1. 119±0. 035 ,A), (53.3 ± 2. 4) %, respectively] and ConA + CD28mAb. CD137 mAb had less effect on both groups than did CD28 mAb. Conclusions (1) Similar age-associated alterations happen in T cells of both D-gal group and aged group. (2) CD137 and CD28 can promote the activation and survival of T cells in aged and D-gal group. But CD28 has stronger effect on regulation of T cells than CD137.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2006年第9期687-690,共4页 Chinese Journal of Geriatrics
关键词 T淋巴细胞 细胞衰老 半乳糖 T-Lymphocytes cell aging Galactose
  • 相关文献

参考文献6

  • 1Schindowski K, Frohlich L, Maurer K, et al. Agerelated impairment of human T lymphocytes'activation: specific differences between CD4 ( + ) and CD8(+) subsets. Mech Ageing Dev, 2002, 123: 375-390.
  • 2孙鹏,郭明秋,陈立茵,陈练波,曹巧莉.亚急性衰老小鼠脾脏T细胞CD137表达的研究[J].细胞与分子免疫学杂志,2002,18(5):429-431. 被引量:5
  • 3Pratima BP, Croft M. Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137). J Immunol, 2002,169: 5005-5009.
  • 4Effros RB. Costimulatory mechanisms in the elderly.Vaccine, 2000, 18: 1661-1665.
  • 5Makiko UG, Yasuhiro K, Akitsu T, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol, 2002, 158: 227-233.
  • 6Linton P, Thoman ML. T cell senescence. Front Biosci, 2001, 6: D248-D261.

二级参考文献7

  • 1[1]Pollok KE,Kim YJ.Inducible T cell antigen 4-1BB.Analysis of expression and function[J].J Immunol,1993,150:771-781.
  • 2[2]Vinay DS,Kwon BS.Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells[J].Cell Immunol,1999,192(1): 63-71.
  • 3[3]Kosman DJ.Galactose oxidase.In: Rene LD,ed.Copper Proteins and Copper Enzymes[M].Vol II.Florida,CRC Press Inc,1984:1-26.
  • 4[4]Lebel CP,Bondy SC.Oxidative damage and cerebral aging[J].Prog Neurob,1992,38:601-609.
  • 5[5]Tan JT,Whitmire JK.4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination[J].J Immunol,2000,164(5): 2320-2325.
  • 6[6]Sansoni P,Cossarizza A.Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians[J].Blood,1993,80:2767-2773.
  • 7[7]DeBenedette MA,Wen T.Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus[J].J Immunol,1999,163(9): 4833-4841.

共引文献4

同被引文献34

  • 1高希言,王燕.艾灸督脉穴对D-半乳糖致亚急性衰老小鼠免疫功能的影响[J].中国针灸,2004,24(7):488-490. 被引量:30
  • 2杨琳,郭明秋,陈立茵.CD137分子对衰老小鼠T细胞活化的影响[J].中国老年学杂志,2005,25(6):685-687. 被引量:5
  • 3徐颖,张志雄,沈蓉,王星禹,李云.电针对记忆障碍大鼠行为学及海马细胞因子的影响[J].针刺研究,2007,32(2):88-92. 被引量:9
  • 4Chu NR, DeBenedette MA, Stiernholm BJ, et al. Role of IL-12 and 4-1BB ligand in cytokine production by CD28^+ and CD28^- T cells [J]. J Immunol, 1997, 158: 3081-9.
  • 5DeBenedette MA, Shahinian A, Mak TW, et al. Costimulation of CD28- T lymphocytes by 4-1BB ligand[J]. J Immunol, 1997, 158: 551-9.
  • 6Hurtado JC, Kim SH, Pollok KE, et al. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28 [J]. J Immtmol, 1995, 155: 3360-67.
  • 7Ito F, Li Q, Andrew B. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines [ J ]. Cancer Res, 2004, 64:8411-9.
  • 8Helmut RS. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells[J]. J Immunol, 2000, 165: 2903-10.
  • 9Sollner L, Shaqireen MM, Kwajah DO, et al. Signal transduction mechanisms of CD 137 ligand in human monocytes [ J ]. Cell Signal, 2007, 19(9): 1899-908.
  • 10Salih HR. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies [ J ]. J Immunol, 2001, 167: 4059-66.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部